Current Issue

View Larger Image

Past Issues Adlink Subscription Visit Our Publisher

ADVERTISEMENT



Top Keywords




News center

Newproductwatch

Molecular Devices

Low-Volume Microplate

UVP

Imaging System with CCD Camera

Pall Life Sciences

Ion Exchange Chromatography Units

Phalanx Biotech Group

microRNA Expression Profiling

QImaging

High-Speed Fluorescence Imaging

Updated every 20 minutes.

Industry updates

BLOG biotech

Video channel

For more videos, check out GEN's YouTube channel.

James Wilson, M.D., Ph.D., on gene therapy as a disruptive technology

Dr. James Wilson is a professor in the department of pathology and laboratory medicine, and the director of the gene therapy program, at the University of Pennsylvania. He is also the editor of Human Gene Therapy, a peer-reviewed journal published by Mary Ann Liebert, Inc. During this interview with GEN, Dr. Wilson discusses his concept of a disruptive technology and explains why he believes gene therapy falls into this category.

In addition to this SKYPE interview, Dr. Wilson further elaborated on his view of gene therapy as a disruptive technology in a column in the January 2012 issue of Human Gene Therapy which you can access by clicking here.

Application note library

Leverage our free Application Note Library to make smarter technology and service purchasing decisions. We will post technical white papers and application notes from leading tool and service providers to keep you up-to-date.

MOST RECENT NOTES:

Content by subject

Biomanufacturing

Biomarkers

Molecular Diagnostics

Stem Cells

Proteomics

Gene Silencing

Genotyping/SNP

PCR

Molecular Diagnostics

High-Content Screening

Subscription center

GEN MAGAZINE

Genetic Engineering & Biotechnology News (GEN) has retained its position as the most widely read biotechnology publication around the globe since its launch in 1981. Published 21 times a year and with additional exclusive editorial content online, GEN's unique news and technology focus includes the entire bioproduct life cycle from early-stage R&D, to applied research including omics, biomarkers, as well as diagnostics, to bioprocessing and commercialization.
e-NEWSLETTERS

Add GEN to your Inbox! Subscribe today to our complimentary e-newsletters and stay abreast of the latest biotech news and trends. Click the magnifying glass icon next to a newsletter title to view a sample.
 

All fields are required
Email
Confirm Email
First Name
Last Name
Organization
E-Alert Format
 
 

ADVERTISEMENT

GEN webinars

« View All Webinars »

ADVERTISEMENT

ADVERTISEMENT

GENpoll

NIH Scientists

Will there be a migration of NIH scientists to the bio industry?

Suggest a Poll
« More »     « View Results »     « Poll Archive »